170 related articles for article (PubMed ID: 10447529)
1. The incretins--outdated terminology in man?
Edwards CM; Bloom SR
Diabetologia; 1999 Sep; 42(9):1148-9. PubMed ID: 10447529
[No Abstract] [Full Text] [Related]
2. The glucagon-like peptides: a double-edged therapeutic sword?
Perry T; Greig NH
Trends Pharmacol Sci; 2003 Jul; 24(7):377-83. PubMed ID: 12871671
[No Abstract] [Full Text] [Related]
3. Learning from the gut.
Mattson MP; Perry T; Greig NH
Nat Med; 2003 Sep; 9(9):1113-5. PubMed ID: 12949521
[No Abstract] [Full Text] [Related]
4. Gastro-intestinal hormones GIP and GLP-1.
Kieffer TJ
Ann Endocrinol (Paris); 2004 Feb; 65(1):13-21. PubMed ID: 15122087
[No Abstract] [Full Text] [Related]
5. [Role of glucagon-like peptide 1 (GLP-1) in regulation of insulin secretion].
Radosavljević T; Todorović V; Sikić B
Srp Arh Celok Lek; 2002; 130(11-12):416-9. PubMed ID: 12751170
[No Abstract] [Full Text] [Related]
6. GLP-1 and the gut.
Thompson DG
Gut; 2000 May; 46(5):591. PubMed ID: 10764696
[No Abstract] [Full Text] [Related]
7. Glucagon-like peptide-1. Gastrointestinal function and possible mechanism of action.
Wettergren A
Dan Med Bull; 2001 Feb; 48(1):19-28. PubMed ID: 11258148
[No Abstract] [Full Text] [Related]
8. [GLP-1 and the control of insulin secretion].
Thorens B
Journ Annu Diabetol Hotel Dieu; 1994; ():33-46. PubMed ID: 8051830
[No Abstract] [Full Text] [Related]
9. Glucagon-like peptide-1, satiety and appetite control.
Blundell JE; Naslund E
Br J Nutr; 1999 Apr; 81(4):259-60. PubMed ID: 10999011
[No Abstract] [Full Text] [Related]
10. Incretin hormones and insulin secretion.
Ahrén B; Gromada J; Schmitz O
Horm Metab Res; 2004; 36(11-12):733-4. PubMed ID: 15655700
[No Abstract] [Full Text] [Related]
11. Is glucagon-like peptide 1 an incretin hormone?
Nauck MA
Diabetologia; 1999 Mar; 42(3):373-9. PubMed ID: 10096792
[TBL] [Abstract][Full Text] [Related]
12. ["Glucagon-like peptide I": a therapeutic alternative for diabetes mellitus?].
Fehmann HC; Göke B
Dtsch Med Wochenschr; 1994 Feb; 119(8):275-9. PubMed ID: 8112212
[No Abstract] [Full Text] [Related]
13. Central glucagon-like peptide-I in the control of feeding.
Gunn I; O'Shea D; Turton MD; Beak SA; Bloom SR
Biochem Soc Trans; 1996 May; 24(2):581-4. PubMed ID: 8736807
[No Abstract] [Full Text] [Related]
14. Overview of incretin hormones.
Efendic S; Portwood N
Horm Metab Res; 2004; 36(11-12):742-6. PubMed ID: 15655702
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism underlying glucagon-like peptide 1 induced calcium mobilization from internal stores in insulin-secreting beta TC3 cells.
Gromada J; Rorsman P
Acta Physiol Scand; 1996 Jul; 157(3):349-51. PubMed ID: 8830891
[No Abstract] [Full Text] [Related]
16. Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
Gromada J; Brock B; Schmitz O; Rorsman P
Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):252-62. PubMed ID: 15569269
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1 and control of insulin secretion.
Thorens B
Diabete Metab; 1995 Dec; 21(5):311-8. PubMed ID: 8586147
[TBL] [Abstract][Full Text] [Related]
18. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
Holst JJ
Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1(7-37)/(7-36)amide is a new incretin.
Fehmann HC; Göke R; Göke B
Mol Cell Endocrinol; 1992 May; 85(1-2):C39-44. PubMed ID: 1382025
[TBL] [Abstract][Full Text] [Related]
20. Human studies with glucagon-like-peptide-1: potential of the gut hormone for clinical use.
Byrne MM; Göke B
Diabet Med; 1996 Oct; 13(10):854-60. PubMed ID: 8911778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
